Thoracic Drainage Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

The global thoracic drainage devices market is estimated to grow at a CAGR of 4.31% during the forecast period from 2024 to 2030. The demand for thoracic drainage devices is primarily being boosted by the increasing prevalence of cardiovascular and pulmonary disorders. Additionally, the growing incidence of heart and thoracic surgeries around the globe is another key factor, which is contributing to the growth of the thoracic drainage devices market during the forecast period from 2024 to 2030.

Thoracic Drainage Devices Market Dynamics:

According to the latest data provided by the World Health Organization 2022, it was estimated that there were around 2.21 million new cases of lung cancer were reported in 2020, globally. Additionally, the same source stated that Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for the highest mortality rates among both men and women. Thoracic drainage devices are commonly used in surgeries for lung cancer treatment. These devices, often referred to as chest tubes, are inserted into the pleural space (the space between the lung and the chest wall) to drain fluid, blood, or air that may accumulate after surgery. Thus, the rising prevalence of lung cancers across the globe will create a need for the management and treatment of such pulmonary disorders, thus resulting in the positive growth of the thoracic drainage devices market.

As per the data provided by the British Heart Foundation 2024, it was estimated that there are around 7.6 million people (4 million men and 3.6 million women) are living with cardiovascular diseases in the UK. The same source stated that more than a million people in the UK are living with heart failure. As the incidence of heart disease rises, there will likely be a higher demand for cardiac surgeries such as coronary artery bypass grafting (CABG), valve replacement, and repair procedures. These surgeries often necessitate the use of thoracic drainage devices for postoperative drainage of fluid and blood. Thus, the rising prevalence of cardiovascular disorders will result in the positive growth of the thoracic drainage devices market during the forecast period.

However, the risk of infection associated with the usage of thoracic drainage devices and stringent regulatory approvals are some of the key constraints that may limit the growth of the thoracic drainage devices market.

Thoracic Drainage Devices Market Segment Analysis:

Thoracic drainage devices market by type (Digital and Traditional), Product (Thoracic Drainage Systems, Thoracic Drainage Kits, Pleural Drainage Catheters, and others) Application (Cardiac Surgery, Thoracic & Pulmonary Surgery, and Others), End-Users (Hospitals, Ambulatory Surgical Centers, and Others), and geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the thoracic drainage devices market, the digital category is estimated to amass a significant revenue share in the thoracic drainage devices market in 2023. This can be attributed to the various advantages provided by the digital thoracic devices. Digital thoracic systems provide real-time monitoring of drainage parameters such as fluid volume, flow rate, and pressure. This allows healthcare providers to closely track the patient's progress and adjust treatment as needed, leading to more precise management of thoracic conditions. Additionally, digital drainage systems may incorporate automated features such as adaptive pressure regulation or intermittent suction modes. These features optimize drainage efficiency while minimizing patient discomfort and reducing the risk of complications such as tissue damage or fluid leakage.

Therefore, owing to the above-mentioned factors, the digital thoracic drainage devices category is expected to register significant growth, thereby driving the growth of the overall thoracic drainage devices market during the forecast period.

North America Is Expected To Dominate The Overall Thoracic Drainage Devices Market:

North America is expected to account for the highest proportion of the thoracic drainage devices market in 2023, out of all regions. This is due to the high prevalence of cardiovascular and pulmonary disorders in the region. Additionally, the presence of sophisticated healthcare infrastructure, robust research and development initiatives, and a highly viable market in terms of product development, and launches are some of the key factors driving the growth of the thoracic drainage devices market in North America.

According to the data provided by the Centers for Disease Control and Prevention 2023, it was stated that about 1 in 20 adults age 20 and older have coronary artery disease in the United States. Additionally, the same source stated that every year, about 805,000 people in the United States have a heart attack. As the incidence of heart diseases rises, there will likely be a higher demand for cardiac surgeries resulting in the usage of thoracic drainage devices during heart surgeries. Thus, the rising prevalence of heart diseases will eventually contribute to the growth of the thoracic drainage devices market in the United States, which will eventually boost the thoracic drainage devices market in North America.

Further, various key product launches and product approvals in the region are some of the other factors that are influencing the positive growth of the market in North America. In December 2023, Bearpac Medical, LLC announced that the US FDA has granted 510(k) clearance for the Passio Pump Drainage System for the additional indication of peritoneal to provide therapy for malignant ascites in addition to recurrent pleural effusions.

Therefore, the factors mentioned above, are some of the important factors that are thereby responsible for driving the overall market for thoracic drainage devices in North America during the forecast period.

Thoracic Drainage Devices Market Key Players:

Some of the key market players operating in the thoracic drainage devices market include Cardinal Health, Getinge AB, BD, Teleflex Incorporated., Cook, Medline Industries, ATMOS MedizinTechnik GmbH & Co. KG, Utah Medical Products, Inc., Vygon SA, Medela, Redax, Sinapi Biomedical, Smiths Group Plc, Vivomed Ltd., Sterimed Group, EUROSETS, ANGIPLAST PRIVATE LIMITED, and others.

Recent Developmental Activities In The Thoracic Drainage Devices Market:

• In April 2022, Bearpac Medical, LLC entered into an exclusive distribution agreement with APR Medtech Ltd (Thame, Oxon, UK) to sell the Passio Pump Drainage System, indicated for the intermittent drainage of recurrent and symptomatic pleural effusions and malignant ascites.
• In December 2020, Medela LLC, a global leader in medical vacuum technology, today announced that its Thopaz+ Digital Chest Drainage and Monitoring System has undergone multiple quantitative tests that demonstrate its filtration system effectively blocks passage of aerosolized viral particles such as SARS-CoV-2, the virus responsible for COVID-19.

Key Takeaways From The Thoracic Drainage Devices Market Report Study

• Market size analysis for current thoracic drainage devices market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the thoracic drainage devices market.
• Various opportunities available for the other competitors in the thoracic drainage devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current thoracic drainage devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for thoracic drainage devices market growth in the coming future?

Target Audience Who Can Be Benefited From This Thoracic Drainage Devices Market Report Study

• Thoracic drainage devices product providers
• Research organizations and consulting companies
• Thoracic drainage devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in thoracic drainage devices
• Various end-users who want to know more about the thoracic drainage devices market and the latest technological developments in the thoracic drainage devices market.

Frequently Asked Questions For The Thoracic Drainage Devices Market:

1. What is meant by thoracic drainage devices market?

Thoracic drainage devices, also known as chest drainage systems, are medical devices used to remove air, fluid, or pus from the pleural space (the space between the lungs and the chest wall) or from the mediastinum (the central compartment of the thoracic cavity).

2. What is the market for thoracic drainage devices?

The global thoracic drainage devices market is estimated to grow at a CAGR of 4.31% during the forecast period from 2024 to 2030.

3. What are the drivers for the global thoracic drainage devices market?

The thoracic drainage devices market is slated to witness prosperity owing to factors such as the increasing prevalence of cardiovascular and pulmonary disorders. Additionally, the growing incidence of heart and thoracic surgeries around the globe is another key factor, which is contributing to the growth of the thoracic drainage devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the global thoracic drainage devices market?

Some of the key market players operating in the thoracic drainage devices market include, Cardinal Health, Getinge AB, BD, Teleflex Incorporated., Cook, Medline Industries, ATMOS MedizinTechnik GmbH & Co. KG, Utah Medical Products, Inc., Vygon SA, Medela, Redax, Sinapi Biomedical, Smiths Group Plc, Vivomed Ltd., Sterimed Group, EUROSETS, ANGIPLAST PRIVATE LIMITED, and others.

5. Which region has the highest share in the global thoracic drainage devices market?

North America is expected to dominate the overall thoracic drainage devices market during the forecast period, 2024 to 2030. This is due to the high prevalence of cardiovascular and pulmonary disorders in the region. Additionally, the presence of sophisticated healthcare infrastructure, robust research and development initiatives, and a highly viable market in terms of product development, and launches are some of the key factors driving the growth of the thoracic drainage devices market in North America.


This product will be delivered within 2 business days.